References

• Abram, S. V., Barbosa, D. A. N., Cunningham, T. N., Feng, A., Parker, J. J., Basit, A. S., Tharin, S. A., Wu, H., & Halpern, C. H. (2025). Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide. Nature Medicine, 31(12), 4038–4043. https://doi.org/10.1038/s41591-025-04035-5
• ulik, C. M., Coleman, J. R. I., Hardaway, J. A., Breithaupt, L., Watson, H. J., Bryant, C. D., & Breen, G. (2022). Genetics and neurobiology of eating disorders. Nature Neuroscience, 25(5), 543–554. https://doi.org/10.1038/s41593-022-01071-z
• Bartel, S., McElroy, S. L., Levangie, D., & Keshen, A. (2024). Use of glucagon-like peptide-1 receptor agonists in eating disorder populations. The International journal of eating disorders, 57(2), 286–293. https://doi.org/10.1002/eat.24109